The FDA signaled escalating enforcement, and on April 30, 2026, it proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list - the mechanism that governs which substances large-scale compounders may use - with a public comment period open through June 29, 2026
Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men
Possible causes: dead space accumulation (discussed above), inaccurate water volume at reconstitution (more water means more dilute, means more volume per dose, means fewer doses from the same amount of peptide), or air in the vial displacing solution
Book an appointment and take the first step toward better health
While occasional returns to the fridge are fine (and better than leaving it out), try to minimize the number of warming cycles